Inducible activation of Ras and Raf in adult epidermis.

Ras effects vary with developmental setting, with oncogenic RAS activation implicated in epithelial carcinogenesis. In epidermal cells, previous studies described conflicting Ras impacts on growth and differentiation, with the only in vivo studies relying on constitutive alterations of Ras function throughout development. To study Ras effects in developmentally mature adult epidermis, we expressed a 4-hydroxytamoxifen (4OHT)-regulated Ras fusion in transgenic mice using the keratin 14 promoter. Resulting adult K14-ER:Ras mice displayed 4OHT-inducible activation of Ras as well as elements of Raf/mitogen-activated protein kinase (MAPK) but not RalGDS/Ral or phosphatidylinositol 3'-kinase (PI3K)/Akt downstream Ras effector pathways. Ras reversibly induced massive cutaneous hyperplasia and suppressed differentiation. Ras-driven hyperproliferation was accompanied by increases in beta1 and beta4 integrin epidermal progenitor markers. Epidermal expression of inducible Raf produced similar changes. These findings indicate that activation of Ras in adult epidermis promotes proliferation and inhibits differentiation and that Raf is sufficient to mediate these effects.

[1]  Amy Li,et al.  Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Watt,et al.  Signaling via b 1 integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro ( keratinocyte y adhesiveness ) , 1999 .

[3]  S. Yuspa,et al.  The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. , 1998, Journal of dermatological science.

[4]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[5]  W. Pierceall,et al.  Ras gene mutation and amplification in human nonmelanoma skin cancers , 1991, Molecular carcinogenesis.

[6]  R. Wolthuis,et al.  Ras-dependent activation of the small GTPase Ral , 1998, Current Biology.

[7]  P. Crespo,et al.  Ras proteins in the control of the cell cycle and cell differentiation , 2000, Cellular and Molecular Life Sciences CMLS.

[8]  C. Marshall.  Small GTPases and cell cycle regulation. , 1999, Biochemical Society transactions.

[9]  C. Berking,et al.  Photocarcinogenesis in human adult skin grafts. , 2002, Carcinogenesis.

[10]  P. Khavari,et al.  Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation , 2002, Oncogene.

[11]  L. Trusolino,et al.  Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: Basal but not squamous cell carcinomas display loss of α6β4 and BM-600/nicein , 1993 .

[12]  D. Roop,et al.  Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v‐Ha‐ras oncogene , 1993, Molecular carcinogenesis.

[13]  E. Génot,et al.  p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes , 1998, Oncogene.

[14]  F. Otsuka,et al.  Changes of cytokeratin and involucrin expression in squamous cell carcinomas of the skin during progression to malignancy , 1995, The British journal of dermatology.

[15]  Nissi M. Varki,et al.  Ras activation in human breast cancer , 2000, Breast Cancer Research and Treatment.

[16]  A. Balmain,et al.  The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted , 1998, Current Biology.

[17]  A. Balmain,et al.  Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter , 1990, Cell.

[18]  S. Yuspa.  The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis--thirty-third G. H. A. Clowes Memorial Award Lecture. , 1994, Cancer research.

[19]  C. Der,et al.  The coupling of α6β4 integrin to Ras–MAP kinase pathways mediated by Shc controls keratinocyte proliferation , 1997 .

[20]  J. Bos,et al.  Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras , 1997, Oncogene.

[21]  C. Der,et al.  The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. , 1997, The EMBO journal.

[22]  F. Watt,et al.  p19ARF‐independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes , 2001, EMBO reports.

[23]  S. Yuspa,et al.  Multistage carcinogenesis in the skin. , 1996, The journal of investigative dermatology. Symposium proceedings.

[24]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[25]  M. Ewen.  Relationship between Ras pathways and cell cycle control. , 2000, Progress in cell cycle research.

[26]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[27]  S. Lowe,et al.  Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Takayama,et al.  Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.